TH154078A - Pharmaceutical ingredients containing fimazartan and hydrochlorothiazide. - Google Patents
Pharmaceutical ingredients containing fimazartan and hydrochlorothiazide.Info
- Publication number
- TH154078A TH154078A TH1401007707A TH1401007707A TH154078A TH 154078 A TH154078 A TH 154078A TH 1401007707 A TH1401007707 A TH 1401007707A TH 1401007707 A TH1401007707 A TH 1401007707A TH 154078 A TH154078 A TH 154078A
- Authority
- TH
- Thailand
- Prior art keywords
- hydrochlorothiazide
- pharmaceutical ingredients
- preparation
- superior
- ingredients
- Prior art date
Links
- 239000004615 ingredient Substances 0.000 title claims abstract 10
- JZUFKLXOESDKRF-UHFFFAOYSA-N Dichlothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 title claims abstract 9
- 229960002003 hydrochlorothiazide Drugs 0.000 title claims abstract 9
- 239000003814 drug Substances 0.000 claims abstract 6
- 229940079593 drugs Drugs 0.000 claims abstract 5
- 230000000704 physical effect Effects 0.000 claims abstract 4
- AMEROGPZOLAFBN-UHFFFAOYSA-N 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide Chemical compound CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 AMEROGPZOLAFBN-UHFFFAOYSA-N 0.000 claims 3
- 239000005475 Fimasartan Substances 0.000 claims 3
- 229960003489 fimasartan Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
Abstract
DC60 (09/03/58) การประดิษฐ์นี้จัดให้มี ส่วนผสมทางเภสัชกรรมที่มีคุณสมบัติทางกายภาพที่เหนือกว่าเนื่องจากฟิมา ซาร์แทนและไฮโดรคลอโรไธอะไซด์ ซึ่งเป็นส่วนประกอบหลักของตำรับเตรียมแบบผสมนั้นมีความ สม่ำเสมอของปริมาณตัวยาที่เหนือกว่า; และวิธีการในการจัดเตรียมของส่วนผสมนั้น แก้ไข 9/3/2558 การประดิษฐ์นี้จัดให้มี: ส่วนผสมทงเภสัชกรรมที่มีคุณสมบัติทางกายภาพที่เหนือกว่าเนื่องจากฟิมา ซาร์แทนและไฮโดรคลอโรไธอะไซด์ ซึ่งเป็นส่วนประกอบหลักของการเตรียมแบบผสมนั้นมีความ สม่ำเสอมของปริมาณตัวยาที่เหนือกว่า; และวิธีการในการจัดเตรียมของส่วนผสมนั้น: สิทธิบัตรยา DC60 (09/03/15) This invention provides Pharmaceutical ingredients with superior physical properties due to the Sartan and hydrochlorothiazide Which is the main component of a mixed preparation recipe Superior drug dosage consistency; And the method for the preparation of the ingredients. Amended 9/3/2015 This invention provides: Pharmaceutical ingredients with superior physical properties due to the Sartan and hydrochlorothiazide Which are the main components of the mixed preparation are Random amounts of a superior drug; And the method for the preparation of that ingredient: drug patent
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH154078A true TH154078A (en) | 2016-07-06 |
| TH1401007707A TH1401007707A (en) | 2016-07-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018076601A2 (en) | oral pharmaceutical formulation, methods for treating a patient, and use of a formulation | |
| CY1123649T1 (en) | IMIDAZOLINE DERIVATIVES, METHODS OF THEIR PREPARATION AND THEIR APPLICATIONS IN MEDICINE | |
| BR112016001678A2 (en) | COMPOSITION, METHOD OF MANUFACTURE OF A TABLET, TABLET, UNIT DOSAGE FORM, ARTICLE OF MANUFACTURE, AND, USE OF A COMPOSITION, TABLET OR UNIT DOSAGE FORM | |
| BR112016028288A2 (en) | compound, pharmaceutical composition, methods for treating an individual with a disease or condition and for inhibiting kinase, and use of a compound. | |
| EA202091115A1 (en) | QUINAZOLINE DERIVATIVES USED FOR HIV TREATMENT | |
| MX2017003561A (en) | Compositions and methods for cannabinoid coatings for use in drug delivery. | |
| UA111434C2 (en) | Pharmaceutical composition containing fimasartan and hydrochlorothiazide | |
| BR112017013998A2 (en) | New Benzimidazole Derivatives as Antihistamines | |
| TH154078A (en) | Pharmaceutical ingredients containing fimazartan and hydrochlorothiazide. | |
| BR112019008516A2 (en) | 3,4-bipyridyl pyrazole derivative, and method of preparation for it and medical application thereof | |
| UY36958A (en) | COMPOUNDS FOR INTRACELLULAR ADMINISTRATION | |
| CL2017000026A1 (en) | Pharmaceutical dosage forms | |
| TH1401007707A (en) | Pharmaceutical ingredients containing fimasartan and hydrochlorothiazide. | |
| GR1008442B (en) | Pharmaceutical formulation containing aripiprazole or salt thereof | |
| TH167583A (en) | Carboxamide derivatives | |
| TH178555A (en) | Heteroerril derivatives Or its pharmaceutical acceptable salt, method of preparation, and pharmaceutical constituents for the prevention or treatment of disease. Associated with PI3 kinase, which has the same thing as active ingredient. | |
| TH147913A (en) | Pharmaceutical mixtures containing olmesartan medoxomil (OLMESARTAN MEDOXOMIL) and rosuvastatin. (ROSUVASTATIN) or salts of these substances. | |
| TH158333A (en) | A pharmaceutical compound capsule formulation containing Urbazar And an HMG-COA reductase inhibitor | |
| TH1801002665A (en) | Compound 7- (thiazol-5-il) pyrolopyrimidine is TLR7 agonist. | |
| ECSP18023423A (en) | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | |
| Liang | An addiction to unsafe injection medication practices? | |
| TH166746A (en) | Stable liquid recipe | |
| TH181225A (en) | ||
| TH162211A (en) | Compound 2-piridone | |
| TH157676A (en) | Pyrazole compounds as SGLT1 inhibitors |